Entero Healthcare Solutions (ENTERO.NS) Jumps 5.17% to ₹1,551.3, Reclaiming the Middle of Its Trading Range - Hull Moving Average
NiveshIQ
Entero Healthcare Solutions Ltd.
NiveshIQ has detected 5 active signals on ENTERO. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeAbout Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited, incorporated in 2018 and headquartered in Mumbai, operates as a diversified healthcare distributor and private label manufacturer, offering pharmaceuticals, nutraceuticals, vaccines, medical devices such as orthopaedic implants and coronary stents, and hospital consumables to retail pharmacies, hospitals, and clinics. The company’s core revenue drivers include the sale of surgical products and medical devices, with a recent focus on expanding its private label portfolio under Entero Surgicals. In Q2 FY27, the Reg 74(5) certificate confirmed compliance with regulatory requirements, reinforcing its operational credibility. The issuance of 43,155 ESOP shares in 2023 has increased employee ownership and aligned incentives with shareholder value. Entero’s ac
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,922 Cr +128.60% | ₹5,096 Cr +29.92% | ₹6,591 Cr +29.35% |
| EBITDA Margin | 2.85% | 3.37% | 4.03% |
| Net Profit | ₹39.11 Cr | ₹94.82 Cr +142.45% | ₹115.04 Cr +21.33% |
| EPS | ₹10.81 | ₹21.80 | ₹26.44 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
HDFC Pharma and Healthcare Reg Gr NAV, Mutual Fund Returns & Scheme History
Entero Healthcare Solutions Limited Estimates – NSE:ENTERO
Strategic Outlook
- Q1FY27 results: revenue ₹1, 940 Cr, PAT ₹38 Cr, EPS ₹8.77, EBITDA margin 5.0%. Growth context: revenue YoY +38.2%, PAT YoY +37.3%, revenue QoQ +1.6%, PAT QoQ +36.2%. Street verdict: strong beat, revenue surprise +5.6%, PAT surprise +75.8%.
Test volumes, test mix, B2B/reference-lab traction, pricing discipline, and operating leverage remain the key forward dr...
FY26 (last completed FY): revenue ₹6, 591 Cr, PAT ₹115 Cr, EBITDA margin 4.0%, EPS ₹26.44. Year-on-year: revenue YoY +29...
More Consumer Services stocks
Everything you unlock with a free account
Frequently Asked Questions
What AI signals does NiveshIQ provide for Entero Healthcare Solutions Ltd.?
NiveshIQ detects active intelligence signals for Entero Healthcare Solutions Ltd. (ENTERO) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Entero Healthcare Solutions Ltd.?
Entero Healthcare Solutions Ltd. operates in the Consumer Services sector with a market capitalisation of ₹540,991.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.